Cargando…
Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?
The number of individuals affected by psychostimulant use disorder (PSUD) has increased rapidly over the last few decades resulting in economic, emotional, and physical burdens on our society. Further compounding this issue is the current lack of clinically approved medications to treat this disorde...
Autores principales: | Hersey, Melinda, Bacon, Amanda K., Bailey, Lydia G., Coggiano, Mark A., Newman, Amy H., Leggio, Lorenzo, Tanda, Gianluigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187604/ https://www.ncbi.nlm.nih.gov/pubmed/34121988 http://dx.doi.org/10.3389/fnins.2021.656475 |
Ejemplares similares
-
Are There Prevalent Sex Differences in Psychostimulant Use Disorder? A Focus on the Potential Therapeutic Efficacy of Atypical Dopamine Uptake Inhibitors
por: Hersey, Melinda, et al.
Publicado: (2023) -
Psychostimulants Modafinil, Atomoxetine and Guanfacine Impair Bone Cell Differentiation and MSC Migration
por: Wagener, Nele, et al.
Publicado: (2022) -
Daytime sleepiness in elderly Parkinson’s disease patients and treatment with the psychostimulant modafinil: A preliminary study
por: Lökk, Johan
Publicado: (2010) -
Pitolisant, a wake‐promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol
por: Krief, Stéphane, et al.
Publicado: (2021) -
Characterization of Highper, an ENU-induced mouse mutant with abnormal psychostimulant and stress responses
por: Eisener-Dorman, Amy F., et al.
Publicado: (2012)